Clinical Trial

Impella ECP Early Feasibility Study

Study acronym: ECP EFS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The Impella ECP EFS is a prospective, multicenter, single-arm, feasibility study evaluating the safety of the Impella ECP device in adult patients undergoing an elective or urgent high-risk percutaneous coronary intervention.
Protocol Amendment History 26 amendments
This ClinicalTrials.gov record has been amended 26 times since 2020-07-17; most recent amendment 2026-04-09.
Status change: Recruiting → Active, Not Recruiting 2023-05-25
Status change: Not Yet Recruiting → Recruiting 2020-10-21
Trial Details
NCT Number NCT04477603
Lead Sponsor Abiomed Inc.
Conditions High-risk Percutaneous Coronary Intervention
Enrollment 100 participants
Start Date 2020-10-09
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-14